Schedule 13G ownership disclosure

REPROS THERAPEUTICS INC.

Security class unavailable · CUSIP: 76028H209

Event date: 2017-07-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,105,626
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-17-000620
Form type
SC 13G
Filer
REPROS THERAPEUTICS INC.
CIK
CIK 897075
Filed
Jul 24, 2017
Reporting period
Jul 20, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub